Oncological and complication assessment of CO2 laser-assisted endoscopic surgery for T1-T2 glottic tumours: clinical experience
- PMID: 27214828
- PMCID: PMC4977004
- DOI: 10.14639/0392-100X-643
Oncological and complication assessment of CO2 laser-assisted endoscopic surgery for T1-T2 glottic tumours: clinical experience
Abstract
Several therapeutic options are used for treatment of early stage glottic carcinoma (Tis/T1/T2): open partial laryngectomy (OPL), radiotherapy and CO2 laser-assisted endoscopic surgery. Laser surgery has gradually gained approval in the management of laryngeal cancer. We present our experience in endoscopic laser surgery for early stage glottic carcinomas. This was a retrospective analysis of 72 patients with T1-T2 glottic cancer treated with laser cordectomy between 2006 and 2012. All patients had at least a 36-month follow-up period. Percentages for disease-specific survival, disease-free survival (DFS) and laryngeal preservation rates were 98.6%, 84.7% and 97.2% respectively. Considering neoplastic features that could predict long-term oncological outcome, tumoural involvement of anterior commissure and pathological staging (pT) significantly correlate with local recurrence (p = 0.021 and p = 0.035) and with a lowered DFS (p = 0.017 and p = 0.023). Other variables such as clinical staging, type of cordectomy, involvement of other structures and surgical margin status showed no significant impact on oncological endpoints. CO2 laser surgery is a reliable technique for T1-T2 glottic cancer considering oncological outcomes. The recurrence rate seems to be affected by involvement of anterior commissure and pT stage.
Esistono numerose strategie terapeutiche per il trattamento del carcinoma glottico in stadio iniziale (Tis/T1/T2): la laringectomia parziale a cielo aperto, la radioterapia e la chirurgia endoscopica condotta mediante laser CO2. In particolare quest’ultimo approccio ha gradualmente, ma inesorabilmente, acquisito un ruolo sempre più centrale nel management del cancro laringeo. In questo lavoro presentiamo la nostra esperienza in materia di chirurgia endoscopica laser-assistita delle neoplasie glottiche in stadio iniziale. è stata realizzata un’analisi retrospettiva su un campione di 72 pazienti affetti da carcinoma glottico in classe T1-T2 trattati con cordectomia laser endoscopica nel periodo compreso tra il 2006 e il 2012. Tutti i pazienti avevano almeno 36 mesi di follow-up. La disease-specific survival, la disease-free survival (DFS) e il tasso di preservazione laringea rilevati con il presente studio sono stati rispettivamente del 98,6%, 84,7% e 97,2%. Analizzando l’influenza sull’outcome oncologico a lungo termine di alcune tra le principali caratteristiche della malattia o del trattamento eseguito, abbiamo riscontrato come il coinvolgimento da parte del tumore della commissura anteriore e lo staging patologico della neoplasia (pT) correlino significativamente con un aumentato tasso di recidiva locale (p = 0,021 e p = 0,035) e con una ridotta DFS (p = 0,017 e p = 0,023). Gli altri parametri presi in esame, come staging clinico, tipo di cordectomia, coinvolgimento di altre specifiche sottosedi laringee e stato dei margini di resezione, non si sono dimostrati, invece, correlare significativamente con gli endpoint oncologici stabiliti. La chirurgia endoscopica laser-assistita è quindi una tecnica estremamente affidabile per il trattamento dei tumori glottici in stadio iniziale in termini di outcome oncologico. Il tasso di recidiva risulta significativamente influenzato dal coinvolgimento della commissura anteriore e dal pT.
Keywords: CO2 laser-surgery; Early stage; Endoscopic cordectomy; Glottic carcinoma; Laryngeal cancer; Larynx.
© Copyright by Società Italiana di Otorinolaringologia e Chirurgia Cervico-Facciale, Rome, Italy.
Figures




Similar articles
-
[The complications after CO2 laser endoscopic surgery for early glottic cancer].Otolaryngol Pol. 2011 Sep;65(5 Suppl):78-84. doi: 10.1016/S0030-6657(11)70713-2. Otolaryngol Pol. 2011. PMID: 22000255 Polish.
-
Surgical therapy of T1 and selected cases of T2 glottic carcinoma: cordectomy, horizontal glottectomy and CO2 laser endoscopic resection.Tumori. 2000 Jul-Aug;86(4):277-82. doi: 10.1177/030089160008600403. Tumori. 2000. PMID: 11016703
-
Oncological outcomes of early glottic carcinoma treated with transoral robotic surgery.Auris Nasus Larynx. 2019 Apr;46(2):285-293. doi: 10.1016/j.anl.2018.08.015. Epub 2018 Sep 11. Auris Nasus Larynx. 2019. PMID: 30217617
-
Laser Microsurgery Versus Radiotherapy Versus Open Partial Laryngectomy for T2 Laryngeal Carcinoma: A Systematic Review of Oncological Outcomes.Ear Nose Throat J. 2021 Feb;100(1_suppl):51S-58S. doi: 10.1177/0145561320928198. Epub 2020 Jun 8. Ear Nose Throat J. 2021. PMID: 32511005
-
[Endoscopic excisional biopsy with laser CO2 for the diagnosis and treatment of glottic carcinoma (T1-selected T2)].Tumori. 2003 Jul-Aug;89(4 Suppl):263-6. Tumori. 2003. PMID: 12903614 Review. Italian.
Cited by
-
Impact of resection margin status on oncological outcomes after CO2 laser cordectomy.Acta Otorhinolaryngol Ital. 2018 Feb;38(1):24-30. doi: 10.14639/0392-100X-870. Epub 2017 May 22. Acta Otorhinolaryngol Ital. 2018. PMID: 28530251 Free PMC article.
-
Prognosis and Outcomes in Early Stage Glottic Carcinoma Involving the Anterior Commissure Treated with Laser CO2 Surgery: A Retrospective Observational Analysis.Indian J Otolaryngol Head Neck Surg. 2022 Dec;74(Suppl 3):6048-6053. doi: 10.1007/s12070-021-02698-3. Epub 2021 Jun 27. Indian J Otolaryngol Head Neck Surg. 2022. PMID: 36742721 Free PMC article.
-
Management of Early Glottic Cancer Treated by CO2 Laser According to Surgical-Margin Status: A Systematic Review of the Literature.Int Arch Otorhinolaryngol. 2021 Apr;25(2):e301-e308. doi: 10.1055/s-0040-1713922. Epub 2020 Sep 24. Int Arch Otorhinolaryngol. 2021. PMID: 33968237 Free PMC article. Review.
-
Comparison of Current Surgical and Non-Surgical Treatment Strategies for Early and Locally Advanced Stage Glottic Laryngeal Cancer and Their Outcome.Cancers (Basel). 2020 Mar 20;12(3):732. doi: 10.3390/cancers12030732. Cancers (Basel). 2020. PMID: 32244899 Free PMC article. Review.
-
Management of positive resection margins following transoral laser microsurgery for glottic cancer.Laryngoscope Investig Otolaryngol. 2023 Nov 23;8(6):1579-1583. doi: 10.1002/lio2.1184. eCollection 2023 Dec. Laryngoscope Investig Otolaryngol. 2023. PMID: 38130264 Free PMC article.
References
-
- Schultz P. Vocal fold cancer. Eur Ann Otorhinolaryngol Head Neck Dis. 2011;128:301–308. - PubMed
-
- Mendenhall WM, Werning JW, Hinerman RW, et al. Management of T1-T2 glottic carcinomas. Cancer. 2004;100:1786–1792. - PubMed
-
- Hartl DM. Evidence-based practice: management of glottic cancer. Otolaryngol Clin North Am. 2012;45:1143–1161. - PubMed
-
- Succo G, Crosetti E, Bertolin A, et al. Benefits and drawbacks of open partial horizontal laryngectomies, Part A: Early-intermediate stage glottic carcinoma. Nead Neck. 2016;38(Suppl 1):E333–E340. - PubMed
-
- Mendenhall WM, Amdur RJ, Morris CG, et al. T1-T2N0 squamous cell carcinoma of the glottic larynx treated with radiation therapy. J Clin Oncol. 2001;19:4029–4036. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical